摘要
目的观察阿奇霉素联合小儿肺热咳喘口服液治疗儿童支原体肺炎的临床效果。方法选取新乡医学院第三附属医院住院治疗的68例支原体肺炎患儿,随机分为观察组和对照组,观察组患儿采用静脉滴注阿奇霉素联合口服小儿肺热咳喘口服液治疗,对照组患儿仅采用静脉滴注阿奇霉素治疗;观察2组患儿体温恢复正常时间、症状控制时间、肺内啰音消失时间、不良反应发生情况及治疗效果。结果治疗后观察组患儿治疗总有效率为94.12%,对照组患儿为73.53%,观察组治疗总有效率明显高于对照组(P<0.05);观察组患儿体温恢复正常时间、症状控制时间、肺内啰音消失时间均显著短于对照组(P<0.05);不良反应发生率2组患儿比较差异无统计学意义(P>0.05)。结论采用阿奇霉素联合小儿肺热咳喘口服液治疗儿童支原体肺炎临床疗效佳,且安全可靠。
Objective To observe the clinical effects of azithromycin combined with infantile feirekechuan oral solution for mycoplasma pneumonia in children. Methods Sixty-eight children with mycoplasma pneumonia from the Third Affiliated Hospital of Xinxiang Medical University were selected and randomly divided into observation group and control group. The children in the observation group were treated with azithromycin by intravenous drip and infantile feirekechuan oral solution. The children in the control group were treated with azithromycin by intravenous drip. The time of body temperature recovery,symptom control,pulmonary rales disappeared,the adverse reaction and clinical effects of the children in the two groups were observed and recorded. Results The effective rate of patients in the observation group was 94. 12%,which was significantly higher than that in the control group（ 73. 53%） after treatment（ P〈0. 05）. The time of temperature recovery,symptom control and pulmonary rales disappeared of patients in the observation group were all shorter than those in the control group（ P〈0. 05）. There was no statistical significance of the incidence of adverse reaction between the two groups（ P〉0. 05）. Conclusion The azithromycin combined with infantile feirekechuan oral solution for mycoplasma pneumonia in children is safe and has better curative effect.
出处
《新乡医学院学报》
CAS
2016年第6期483-484,488,共3页
Journal of Xinxiang Medical University
关键词
阿奇霉素
小儿肺热咳喘口服液
支原体肺炎
儿童
azithromycin
infantile feirekechuan oral solution in children
mycoplasma pneumonia
child
